Can krill oil boost Metformin's benefits for PCOS? small trial hints at possibility
NCT ID NCT07604870
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether adding krill oil to standard metformin therapy improves metabolic health in women with PCOS and obesity. Fifty-four women were split into three groups: metformin alone, krill oil alone, or both together for 8 weeks. Researchers measured changes in blood markers like adiponectin and insulin resistance to see if the combination offers extra benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Krill oil and metformin
- What this could lead to
- If it works, this could point toward a simple supplement-plus-medication approach to improve metabolic health in women with PCOS and obesity.
- What could go wrong
- This is a small pilot trial with only 54 participants and no placebo group, so results are preliminary and may not apply to everyone. Krill oil is a supplement, not a proven treatment for PCOS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Firat University, Faculty of Health Sciences, Department of Nutrition and Dietetics
Elâzığ, 23119, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test